Jia Zhan

Dr. Jia Zhan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Ultrasonography
Verified
Journal Article
Open access
PDF file
JZJia Zhan
Jia Zhan
HDHong Ding
Hong Ding
Contrast-enhanced ultrasound (CEUS) is widely used to evaluate tumor microcirculation, which is useful in the differential diagnosis between benignity and malignancy. In the last 10 years, the applicability of CEUS to thyroid nodules has greatly improved due to technological refinements and the development of second-generation contrast agents. In this review, we summarize the applications of CEUS for thyroid nodules, focusing on the imaging findings of malignant and benign nodules in the existing literature and the use of those findings to predict malignancies, with an additional brief description of the utilization of CEUS for other thyroid-related diseases.

1 December 2020 in Clinical Breast Cancer
Verified
Journal Article
Closed access
XDXuehong Diao
Xuehong Diao
JZJia Zhan
Jia Zhan
LCLin Chen
Lin Chen
YCYue Chen
Yue Chen
HCHongli Cao
Hongli Cao

1 January 2020 in Therapeutic Advances in Medical Oncology
Verified
Journal Article
Open access
PDF file
JZJia Zhan
Jia Zhan
LZLong-Hui Zhang
Long-Hui Zhang
QYQing Yu
Qing Yu
CLChao-Lun Li
Chao-Lun Li
YCYue Chen
Yue Chen
HDHong Ding
Hong Ding
Objective: This study aimed to evaluate the correlation between cervical lymph node metastasis (CLNM) and each of the ultrasound features, immunohistochemical factors, and B-type Raf (BRAFV600E) mutation. Methods: A retrospective analysis was performed on 405 patients with single papillary thyroid carcinoma (PTC) nodules, all of whom underwent preoperative sonographic examinations, including gray-scale ultrasound, color Doppler ultrasound, and contrast-enhanced ultrasound (CEUS). All PTC patients were evaluated using 14 clinical and sonographic features, eight immunohistochemical factors, and BRAFV600E. Multivariate analyses were performed to identify the risk factors for CLNM, and an equation for CLNM was established. The diagnostic value of each modality was compared with a receiver operating characteristic (ROC) curve. Results: Among the 405 PTC nodules removed surgically, CLNM was confirmed in 138 patients, whereas extrathyroidal extension was confirmed in 185 patients. Multivariate analyses indicated significant differences between CLNM and non-CLNM groups in three conventional ultrasound features ( p < 0.05), whereas other sonographic features, eight immunohistochemical factors, and BRAFV600E did not indicate significant differences. A ROC curve of 0.757 in the equation exhibited a significant difference compared with the solo factors ( p < 0.05 for all). Hyper or isoechoic enhancement at peak time on CEUS was associated with CLNM, whereas the presence of the BRAFV600E mutation was associated with extrathyroidal extensions although BRAF appeared to be uncorrelated with CLNM in the present study. Conclusion: Intensity at peak time, homogeneity, and size are the three most significant features in predicting CLNM in PTC patients, and the presence of the BRAFV600E mutation was associated with extrathyroidal extensions when PTCs showed a hyper or isoechoic enhancement at peak time in CEUS.

9 September 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
HCHongli Cao
Hongli Cao
LFLiang Fang
Liang Fang
LCLin Chen
Lin Chen
JZJia Zhan
Jia Zhan
XDXuehong Diao
Xuehong Diao
YCYue Chen
Yue Chen

1 February 2021 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
WDWen-Bin Dai
Wen-Bin Dai
JXJun Xu
Jun Xu
BYBo Yu
Bo Yu
LCLin Chen
Lin Chen
YCYue Chen
Yue Chen
JZJia Zhan
Jia Zhan

1 August 2019 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
WDWen-Bin Dai
Wen-Bin Dai
BYBo Yu
Bo Yu
XDXue-Hong Diao
Xue-Hong Diao
HCHongli Cao
Hongli Cao
LCLin Chen
Lin Chen
JZJia Zhan
Jia Zhan